Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides. 1993

C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
Department of Internal Medicine, Faculty of Medicine, University of Navarra, Pamplona, Spain.

A novel ELISA assay for the detection of anti-hepatitis C virus antibodies in the sera of infected individuals is described. This assay is based on a mixture of three 15-amino acid synthetic peptides encompassing regions of core and NS4 proteins of hepatitis C virus. Comparison with other available ELISA assays based on recombinant polypeptides shows that, short synthetic peptides have the advantage over some larger recombinant peptides by giving higher specificity without loss of sensitivity.

UI MeSH Term Description Entries
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
January 2002, Journal of immunological methods,
C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
January 2011, Journal of virological methods,
C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
October 1992, Clinica chimica acta; international journal of clinical chemistry,
C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
July 2002, Russian journal of immunology : RJI : official journal of Russian Society of Immunology,
C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
July 2013, Expert opinion on investigational drugs,
C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
January 1992, Advances in experimental medicine and biology,
C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
May 1992, Proceedings of the National Academy of Sciences of the United States of America,
C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
July 1991, Gastroenterologia Japonica,
C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
April 1993, Journal of clinical microbiology,
C Berasain, and M García-Granero, and J I Riezu-Boj, and M P Civeira, and J Prieto, and F Borrás-Cuesta
January 2001, Voprosy virusologii,
Copied contents to your clipboard!